Designing antigens for the prevention and treatment of autoimmune diseases

David C. Wraith

doi:10.1016/j.coche.2017.12.004

Designing antigens for the prevention and treatment of autoimmune diseases

David C. Wraith

Immunology and Immunotherapy

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

191 Downloads (Pure)

Abstract

Antigen-specific immunotherapy is considered the holy-grail for treatment of autoimmune diseases. However, unlike the unattainable myth of Arthurian legend, effective antigen-specific immunotherapy is now being realised through clinical trials in patients. This review describes the various approaches being taken, how antigens are being designed for therapy and carriers created for their delivery. A critical assessment is made concerning the need for such carrier systems.

Original language	English
Pages (from-to)	35-42
Number of pages	8
Journal	Current Opinion in Chemical Engineering
Volume	19
Early online date	28 Dec 2017
DOIs	https://doi.org/10.1016/j.coche.2017.12.004
Publication status	Published - Mar 2018

ASJC Scopus subject areas

General Energy

Access to Document

10.1016/j.coche.2017.12.004Licence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

WraithD2018DesigningFinal published version, 637 KBLicence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

Cite this

@article{adb3cc1fdcba4859a57fc277b7769997,

title = "Designing antigens for the prevention and treatment of autoimmune diseases",

abstract = "Antigen-specific immunotherapy is considered the holy-grail for treatment of autoimmune diseases. However, unlike the unattainable myth of Arthurian legend, effective antigen-specific immunotherapy is now being realised through clinical trials in patients. This review describes the various approaches being taken, how antigens are being designed for therapy and carriers created for their delivery. A critical assessment is made concerning the need for such carrier systems.",

author = "Wraith, {David C.}",

year = "2018",

month = mar,

doi = "10.1016/j.coche.2017.12.004",

language = "English",

volume = "19",

pages = "35--42",

journal = "Current Opinion in Chemical Engineering",

issn = "2211-3398",

publisher = "Elsevier",

}

TY - JOUR

T1 - Designing antigens for the prevention and treatment of autoimmune diseases

AU - Wraith, David C.

PY - 2018/3

Y1 - 2018/3

N2 - Antigen-specific immunotherapy is considered the holy-grail for treatment of autoimmune diseases. However, unlike the unattainable myth of Arthurian legend, effective antigen-specific immunotherapy is now being realised through clinical trials in patients. This review describes the various approaches being taken, how antigens are being designed for therapy and carriers created for their delivery. A critical assessment is made concerning the need for such carrier systems.

AB - Antigen-specific immunotherapy is considered the holy-grail for treatment of autoimmune diseases. However, unlike the unattainable myth of Arthurian legend, effective antigen-specific immunotherapy is now being realised through clinical trials in patients. This review describes the various approaches being taken, how antigens are being designed for therapy and carriers created for their delivery. A critical assessment is made concerning the need for such carrier systems.

UR - http://www.scopus.com/inward/record.url?scp=85042362845&partnerID=8YFLogxK

U2 - 10.1016/j.coche.2017.12.004

DO - 10.1016/j.coche.2017.12.004

M3 - Article

AN - SCOPUS:85042362845

SN - 2211-3398

VL - 19

SP - 35

EP - 42

JO - Current Opinion in Chemical Engineering

JF - Current Opinion in Chemical Engineering

ER -

Designing antigens for the prevention and treatment of autoimmune diseases

Abstract

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this